Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
30,165,358
-
Shares change
-
+2,938,463
-
Total reported value, excl. options
-
$593,266,094
-
Value change
-
+$67,324,611
-
Put/Call ratio
-
0%
-
Number of buys
-
80
-
Number of sells
-
37
-
Price
-
$19.67
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q3 2017
As of 30 Sep 2017 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,165,358 shares of stock of the company.
Largest 10 holders included BlackRock Inc., EAGLE ASSET MANAGEMENT INC, Novo Holdings A/S, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Nantahala Capital Management, LLC, STATE STREET CORP, FMR LLC, and FIRST MANHATTAN CO.
This table shows 118 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.